AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27287512 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ONCOS-102 with standard of care chemotherapy (Pemetrexed, Cisplatin, Carboplatin)
Number of subjects: 0
Study 27287512 — intervention group
Group type: COMPARATOR
Intervention: Standard of care chemotherapy (Pemetrexed, Cisplatin, Carboplatin) alone
Number of subjects: 0
Study 27287851 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclatasvir (DCV) plus Asunaprevir (ASV) for 24 weeks
Number of subjects: 222
Study 27287911 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (naïve-to-bypass)
Number of subjects: 134
Study 27287911 — intervention group
Group type: COMPARATOR
Intervention: Conversion from gastric banding to gastric bypass (band-to-bypass)
Number of subjects: 134
Study 27288210 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil 600 mg
Number of subjects: 671
Study 27288210 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil 1200 mg
Number of subjects: 671
Study 27288210 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil 600 mg and 1200 mg
Number of subjects: 671
Study 27288210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671
Study 27288278 — intervention group
Group type: EXPERIMENTAL
Intervention: hsTnI algorithm
Number of subjects: 3128
Study 27288278 — intervention group
Group type: EXPERIMENTAL
Intervention: hsTnT algorithm
Number of subjects: 3128
Study 27288959 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) to the medial forebrain bundle (MFB)
Number of subjects: 4
Study 27288959 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 4
Study 27289552 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of chemoresistant circulating tumour cells (CTCs) after adjuvant chemotherapy
Number of subjects: 350
Study 27289552 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of chemoresistant circulating tumour cells (CTCs) after neoadjuvant chemotherapy
Number of subjects: 350
Study 27291075 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic caregivers
Number of subjects: 864
Study 27291075 — intervention group
Group type: EXPERIMENTAL
Intervention: Black, non-Hispanic caregivers
Number of subjects: 864
Study 27291511 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive ICD programming with lower VF detection zone, no antitachycardia pacing therapies during capacitor charge, and shorter detection times.
Number of subjects: 1319
Study 27291511 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ES
Number of subjects: 1319
Study 27292016 — intervention group
Group type: EXPERIMENTAL
Intervention: Device intervention
Number of subjects: 10000000
Study 27292016 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 10000000
Study 27293200 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) surgery
Number of subjects: 24
Study 27293200 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-surgical)
Number of subjects: 24
Study 27293875 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab injections
Number of subjects: 18
Study 27293875 — intervention group
Group type: COMPARATOR
Intervention: Vitreous surgery or Ahmed valve implantation
Number of subjects: 18
Study 27294305 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine 25 mg qd
Number of subjects: 36
Study 27294708 — intervention group
Group type: EXPERIMENTAL
Intervention: Clickamico app (6-minute video with clown physicians)
Number of subjects: 40
Study 27294708 — intervention group
Group type: COMPARATOR
Intervention: Standard informative intervention
Number of subjects: 40
Study 27294768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hula-based intervention with self-care education
Number of subjects: 55
Study 27294768 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 55
Study 27294768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 55
Study 27294995 — intervention group
Group type: EXPERIMENTAL
Intervention: RA Activities
Number of subjects: 81
Study 27294995 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-Limb Activities
Number of subjects: 81
Study 27294995 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Activities
Number of subjects: 81
Study 27294995 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Autonomy Activities
Number of subjects: 81
Study 27294995 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Conditions for Activities
Number of subjects: 81
Study 27296200 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural high-sensitivity cardiac troponin T (hs-cTnT) elevation (above 14 ng/L)
Number of subjects: 2029
Study 27296200 — intervention group
Group type: COMPARATOR
Intervention: Normal preprocedural hs-cTnT (below 14 ng/L)
Number of subjects: 2029
Study 27296239 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline R-wave amplitudes ≤2.5 mV during follow-up of patients with ICDs
Number of subjects: 2507
Study 27296239 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline R-wave amplitudes ≥2.2 to <7 mV
Number of subjects: 2507
Study 27296239 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline R-wave amplitudes ≥17 mV
Number of subjects: 2507
Study 27296239 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline R-wave amplitudes ≥12 to <17 mV
Number of subjects: 2507
Study 27296239 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline R-wave amplitudes ≥7 to <12 mV
Number of subjects: 2507
Study 27296315 — intervention group
Group type: EXPERIMENTAL
Intervention: Laquinimod
Number of subjects: 0
Study 27296397 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696 (sacubitril/valsartan) 200 mg twice daily for 4 to 6 weeks
Number of subjects: 8442
Study 27296397 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg twice daily for 2 weeks
Number of subjects: 8442
Study 27296397 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696 (sacubitril/valsartan)
Number of subjects: 8442
Study 27296397 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted analysis of randomized treatment
Number of subjects: 8442
Study 27296781 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal iodine-125 seed brachytherapy (144 Gy)
Number of subjects: 20
Study 27296781 — intervention group
Group type: COMPARATOR
Intervention: Standard seed implant (for one patient due to bilateral disease)
Number of subjects: 20
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette actions by doctors
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette actions by midwives
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette actions by other cadres (health assistants, health extension workers)
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital facility type
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic facility type
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Average annual workload per skilled birth attendant
Number of subjects: 64
Study 27297010 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall competence assessment
Number of subjects: 64
Study 27297409 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophils from asthmatic subjects
Number of subjects: 18
Study 27297409 — intervention group
Group type: COMPARATOR
Intervention: Eosinophils from healthy subjects
Number of subjects: 18
Study 27297785 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 17743
Study 27297785 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 17743
Study 27297785 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 17743
Study 27297790 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic cell transplantation (AHCT)
Number of subjects: 43
Study 27297790 — intervention group
Group type: COMPARATOR
Intervention: Control group (151 matched controls)
Number of subjects: 43
Study 27297981 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept treatment
Number of subjects: 955
Study 27298069 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 228
Study 27298069 — intervention group
Group type: COMPARATOR
Intervention: Control for baseline PROMs, septal deviation, steroid-dependent conditions, and medication use variables
Number of subjects: 228
Study 27298729 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year group multi-professional lifestyle intervention with monthly meetings at the paediatric outpatient obesity clinic (n=65)
Number of subjects: 137
Study 27298729 — intervention group
Group type: COMPARATOR
Intervention: Free living phase for one year (Control group, n=72)
Number of subjects: 137
Study 27299735 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicirc disposable instrument under topical anesthetic and wound sealing with cyanoacrylate tissue adhesive
Number of subjects: 75
Study 27299735 — intervention group
Group type: COMPARATOR
Intervention: Open surgical circumcision under local anesthetic with suturing
Number of subjects: 75
Study 27300170 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc intensification
Number of subjects: 21
Study 27300170 — intervention group
Group type: COMPARATOR
Intervention: Control (unchanged cART regimen)
Number of subjects: 21
Study 27300475 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg liraglutide daily (acute administration)
Number of subjects: 10
Study 27300475 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg liraglutide daily (chronic administration)
Number of subjects: 10
Study 27300475 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg liraglutide daily (acute and chronic administration)
Number of subjects: 10
Study 27300572 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature ovarian insufficiency (POI)
Number of subjects: 349
Study 27301652 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Dipyrone
Number of subjects: 41
Study 27301652 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 41
Study 27302554 — intervention group
Group type: EXPERIMENTAL
Intervention: EGAP (Echelle de GrAvité de la Pharmacodépendance) score
Number of subjects: 0
Study 27302623 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based digital intervention (smoking cessation web app)
Number of subjects: 0
Study 27302623 — intervention group
Group type: COMPARATOR
Intervention: Baseline usual care web app
Number of subjects: 0
Study 27302659 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete immunosuppression withdrawal (WISP-R)
Number of subjects: 12
Study 27302980 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 102
Study 27302980 — intervention group
Group type: COMPARATOR
Intervention: Formula
Number of subjects: 102
Study 27303050 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient categorization and scoring system based on 15 rules-based algorithms
Number of subjects: 222
Study 27303062 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy intervention
Number of subjects: 51
Study 27303062 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions targeting pain etiology and assessment
Number of subjects: 51
Study 27303062 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved communication with health-care professionals
Number of subjects: 51
Study 27306058 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) surgery
Number of subjects: 13
Study 27306615 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 27307294 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy (16 mg/kg)
Number of subjects: 102
Study 27307294 — intervention group
Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid
Number of subjects: 102
Study 27307468 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 703920
Study 27307708 — intervention group
Group type: EXPERIMENTAL
Intervention: Agalsidase alfa 0.2 mg/kg every other week for 55 weeks
Number of subjects: 14
Study 27307726 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Oscillation Technique (FOT)
Number of subjects: 158
Study 27308805 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening initial and repeat maternal HIV testing and provider-initiated testing (PITC)
Number of subjects: 183
Study 27308805 — intervention group
Group type: COMPARATOR
Intervention: Maternal HIV testing during pregnancy
Number of subjects: 183
Study 27308805 — intervention group
Group type: COMPARATOR
Intervention: Maternal HIV diagnosis
Number of subjects: 183
Study 27308805 — intervention group
Group type: COMPARATOR
Intervention: PMTCT antiretrovirals
Number of subjects: 183
Study 27308805 — intervention group
Group type: COMPARATOR
Intervention: Missed opportunities for pediatric diagnosis and linkage
Number of subjects: 183
Study 27308805 — intervention group
Group type: COMPARATOR
Intervention: HIV testing among previously hospitalized children
Number of subjects: 183
Study 27309039 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercaloric diet (3 g sucrose/kg body weight per day and 1 g fat/kg body weight per day for 28 days)
Number of subjects: 0
Study 27309344 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer scaffold implanted in the spinal cord parenchyma at T12.
Number of subjects: 1
Study 27309906 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS) for RARS
Number of subjects: 20
Study 27309906 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sinus surgery (ESS) for CRSsNP
Number of subjects: 20
Study 27310205 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX4
Number of subjects: 284
Study 27310205 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Dose-Dense FOLFOX7 followed by FOLFIRI
Number of subjects: 284
Study 27310205 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX4 and FOLFOX7
Number of subjects: 284
Study 27310229 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait Meta-Mood Scale (TMMS)
Number of subjects: 824
Study 27312051 — intervention group
Group type: EXPERIMENTAL
Intervention: SPAG5 gene copy number aberrations
Number of subjects: 5439
Study 27312051 — intervention group
Group type: EXPERIMENTAL
Intervention: High SPAG5 transcript expression
Number of subjects: 5439
Study 27312051 — intervention group
Group type: EXPERIMENTAL
Intervention: High SPAG5 protein expression
Number of subjects: 5439
Study 27312051 — intervention group
Group type: EXPERIMENTAL
Intervention: High SPAG5 transcript and protein concentrations
Number of subjects: 5439
Study 27312051 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline-based adjuvant chemotherapy in oestrogen receptor-negative breast cancer with high SPAG5 protein expression
Number of subjects: 5439
Study 27312699 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Calorie Diet (VLCD)
Number of subjects: 27
Study 27312699 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 27
Study 27312804 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (BP)
Number of subjects: 696
Study 27312804 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (BP)
Number of subjects: 696
Study 27312804 — intervention group
Group type: EXPERIMENTAL
Intervention: History of Hypertension
Number of subjects: 696
Study 27312804 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP
Number of subjects: 696
Study 27313054 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT + PMD
Number of subjects: 60
Study 27313054 — intervention group
Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 60
Study 27313069 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide treatment
Number of subjects: 2
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballard scoring
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker prematurity scorecard
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Capurro method
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Eregie method
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Bhagwat method
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot length <75 mm
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth weight <2500 g
Number of subjects: 1066
Study 27313070 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal anthropometrics
Number of subjects: 1066
Study 27313547 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional case management intervention
Number of subjects: 102
Study 27313547 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up by private psychiatrists or general practitioners
Number of subjects: 102
Study 27313822 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD foam
Number of subjects: 302
Study 27313822 — intervention group
Group type: COMPARATOR
Intervention: Cal foam
Number of subjects: 302
Study 27313822 — intervention group
Group type: COMPARATOR
Intervention: BD foam
Number of subjects: 302
Study 27313846 — intervention group
Group type: EXPERIMENTAL
Intervention: DFA-02 (gentamicin 16.8 mg/mL and vancomycin 18.8 mg/mL)
Number of subjects: 40
Study 27313846 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 40
Study 27313852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheddar cheese high-fat meal
Number of subjects: 20
Study 27313852 — intervention group
Group type: COMPARATOR
Intervention: Vegan-alternative high-fat meal
Number of subjects: 20
Study 27314177 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected individuals
Number of subjects: 155
Study 27314177 — intervention group
Group type: COMPARATOR
Intervention: Non-HIV controls
Number of subjects: 155
Study 27315132 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (100mg starting dose, titrated up to 400mg/day)
Number of subjects: 34
Study 27315764 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based messaging intervention (10 video vignettes grounded in social learning and social cognitive theories)
Number of subjects: 1500
Study 27315764 — intervention group
Group type: COMPARATOR
Intervention: Attention control (10 video vignettes focusing on healthy living)
Number of subjects: 1500
Study 27315835 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated spasticity management including multiple botulinum toxin A (BoNT-A) injection cycles and concomitant therapies
Number of subjects: 1000
Study 27315835 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper Limb Spasticity Index and Goal Attainment Scaling-Evaluation of Outcomes for Upper Limb Spasticity tool
Number of subjects: 1000
Study 27315835 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant therapy inputs and patient satisfaction with engagement in goal setting
Number of subjects: 1000
Study 27316444 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT
Number of subjects: 19
Study 27316444 — intervention group
Group type: EXPERIMENTAL
Intervention: (68)Ga-DOTANOC PET/CT
Number of subjects: 19
Study 27316465 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium + olodaterol
Number of subjects: 0
Study 27316465 — intervention group
Group type: COMPARATOR
Intervention: tiotropium monotherapy
Number of subjects: 0
Study 27316794 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium difficile infection (CDI) cases
Number of subjects: 606058
Study 27316794 — intervention group
Group type: EXPERIMENTAL
Intervention: CDI-attributable deaths
Number of subjects: 606058
Study 27316794 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic burden of CDI
Number of subjects: 606058
Study 27316825 — intervention group
Group type: EXPERIMENTAL
Intervention: ProGrip laparoscopic, self-fixating mesh
Number of subjects: 101
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical microorganisms
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-respiratory season (week 20 to week 39)
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <60 years during non-respiratory season
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP acquired in the non-respiratory season
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <60 years
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 980
Study 27317257 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of COPD
Number of subjects: 980
Study 27317348 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up Reactive Hyperemia Index (RHI) measured at 6 and 9 months post-intervention.
Number of subjects: 249
Study 27317348 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up RHI as a predictor of ISR.
Number of subjects: 249
Study 27317348 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating-characteristic analysis of F/U RHI.
Number of subjects: 249
Study 27317348 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of RHI to traditional ISR risk factors.
Number of subjects: 249
Study 27317471 — intervention group
Group type: COMPARATOR
Intervention: 1 mg midazolam (control phase)
Number of subjects: 12
Study 27317471 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg midazolam after pretreatment with 400 mg ketoconazole once daily for 4 days (CYP3A inhibition phase)
Number of subjects: 12
Study 27317471 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg midazolam after pretreatment with 600 mg rifampicin once daily for 10 days (CYP3A induction phase)
Number of subjects: 12
Study 27317630 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain magnetic resonance imaging (MRI) scans including T1-weighted three-dimensional anatomy scan, diffusion tensor imaging, and resting state functional MRI
Number of subjects: 0
Study 27317630 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental pain testing parameters
Number of subjects: 0